Status:
COMPLETED
Setria Performance Blend Supplementation
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Kirin Holdings Company, Limited
Conditions:
Healthy
Eligibility:
MALE
20-30 years
Phase:
NA
Brief Summary
The objective of this trial is to evaluate the effects of setria performance blend supplementation on endurance performance in healthy men.
Detailed Description
This study is a randomized, double-blind, placebo-controlled crossover trial in healthy men. Subjects will take either a placebo or setria performance blend (L-citrulline + glutathione) for 8 days. At...
Eligibility Criteria
Inclusion
- Participant is an adult male between the ages of 20-30 years
- Participant is aerobically fit, as defined by a VO2max between 42-70 ml\*kg/min (determined by the screening test)
- Participant is not obese (18.5 ≦ BMI \< 30 kg/m²)
- Participant has provided written and dated informed consent to participate in the study
- Participant is willing and able to comply with the protocol
- Participant is apparently healthy and free from disease, as determined by a health history questionnaire
- Participant agrees to refrain from strenuous exercise and alcohol consumption within 24 hours of laboratory visits, and to refrain from caffeine consumption within twelve hours of visits
- Participant agrees to refrain from using antibacterial mouthwash, chewing gum, and brushing their teeth on the morning of laboratory visits
Exclusion
- Participant has consistently used prescription drugs or ergogenic dietary supplements that may influence study outcomes within eight weeks prior to enrollment, or begins to do so during the study. Potential drugs and supplements include but are not limited to whey protein, creatine, beta-alanine, antihypertensive medications, or anabolic steroids
- Participant has gained or lost ≥10 lbs in the previous 2 months
- Participant is enrolled in a separate clinical trial involving diet, exercise, physical activity, or the potential ingestion of an active drug or dietary supplement in the previous 2 months and during this study
- Participant has participated in a clinical trial within the previous 2 months that includes modifications to their physical and/or diet that may influence study outcomes and during this study
- Participant has a known allergy or sensitivity to the placebo or active ingredients
- Participant consumes more than 3 alcoholic drinks per day
- Participant has used tobacco more than three days per week (on average) in the previous eight weeks
- Participant has used recreational drugs within the past month, or refuses to abstain from recreational drug use for the entirety of the study
Key Trial Info
Start Date :
November 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04090138
Start Date
November 30 2019
End Date
November 1 2020
Last Update
April 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Applied Physiology Laboratory, Fetzer Hall Room 25
Chapel Hill, North Carolina, United States, 27599